Blood Clot Retrieval Device Market to Reach USD 9.88 Billion by 2035 | North America Holds 43.5% Market Share | Key Players: AngioDynamics, Imperative Care, Rapid Medical

The global blood clot retrieval device market was valued at USD 2.61 billion in 2025 and is projected to reach USD 9.88 billion by 2035, growing at a CAGR of 14.19% during the forecast period from 2026 to 2035. The market presents a highly attractive growth opportunity driven by the increasing prevalence of ischemic stroke, deep vein thrombosis, pulmonary embolism, and other thromboembolic disorders, coupled with rising demand for minimally invasive neurovascular and cardiovascular interventions. Blood clot retrieval devices are becoming a critical component of modern endovascular treatment by enabling rapid vessel recanalization, improving patient outcomes, and reducing long-term disability. Growing awareness of early stroke intervention, expanding stroke care networks, and increasing investments in advanced interventional healthcare infrastructure are further supporting market expansion.

The market is also witnessing a strategic shift from standalone thrombectomy devices toward comprehensive clot retrieval platforms focused on improving procedural efficiency and clinical outcomes. Healthcare providers are increasingly adopting aspiration-first techniques, large-bore aspiration catheters, and combined mechanical thrombectomy approaches that deliver higher first-pass recanalization rates, faster reperfusion, superior clot capture performance, and improved vessel navigability compared with conventional stent retriever-based procedures. Continuous technological advancements in catheter design, aspiration systems, and imaging-guided navigation are further enhancing treatment success while reducing procedural complications. Leading medical device manufacturers are investing in next-generation thrombectomy technologies, clinical research, and product innovation to strengthen their competitive position. As demand for faster, safer, and more effective stroke interventions continues to rise, the blood clot retrieval device market is expected to offer strong long-term growth potential and an attractive business landscape for manufacturers, healthcare providers, and investors worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/blood-clot-retrieval-device-market?sai-v

Key Developments
June 2026: The United States expanded investments in advanced stroke care infrastructure and neurovascular intervention technologies, accelerating the adoption of blood clot retrieval devices to improve treatment outcomes for patients with acute ischemic stroke.

May 2026: Japan strengthened funding for minimally invasive neurovascular treatment technologies, supporting the development and clinical adoption of next-generation mechanical thrombectomy and blood clot retrieval devices.

April 2026: Leading medical device companies increased investments in advanced blood clot retrieval systems, introducing enhanced aspiration catheters, stent retrievers, and AI-enabled imaging solutions to improve procedural efficiency and clinical outcomes.

March 2026: Global healthcare technology providers expanded partnerships with hospitals and stroke centers to improve access to mechanical thrombectomy procedures, supporting faster diagnosis and timely intervention for stroke patients.

February 2026: Major neurovascular device manufacturers advanced research and development of next-generation clot retrieval technologies, focusing on improved navigation, higher first-pass recanalization rates, and reduced procedural complications.

January 2026: Governments and healthcare organizations increased investments in comprehensive stroke care programs, expanding neurointerventional infrastructure, physician training, and access to blood clot retrieval devices to reduce stroke-related disability and mortality.

Key Players
AngioDynamics, Inc. | Imperative Care, Inc. | Rapid Medical | phenox | ACANDIS GmbH | Balt Group | Vesalio Inc. | Koninklijke Philips N.V. | Others

Key Highlights
AngioDynamics, Inc. - Holds a 19.4% share, driven by its advanced neurovascular intervention portfolio, innovative thrombectomy technologies, and strong presence in minimally invasive stroke treatment.

Imperative Care, Inc. - Holds a 16.2% share, supported by its specialized stroke care solutions, next-generation aspiration technologies, and expanding neurovascular product portfolio.

Rapid Medical - Holds a 13.4% share, strengthened by its innovative neurovascular devices, advanced clot retrieval technologies, and growing adoption in ischemic stroke interventions.

phenox - Holds a 11.2% share, fueled by its specialized thrombectomy and embolization devices, strong clinical evidence, and broad presence in neurovascular procedures.

ACANDIS GmbH - Holds a 9.3% share, supported by its minimally invasive neurovascular implants, catheter technologies, and expanding international distribution network.

Balt Group - Holds a 8.1% share, driven by its comprehensive neurovascular device portfolio, expertise in endovascular treatment, and continuous product innovation.

Vesalio Inc. - Holds a 6.7% share, strengthened by its next-generation stroke intervention technologies, focus on neurovascular innovation, and expanding clinical adoption.

Koninklijke Philips N.V. - Holds a 5.8% share, supported by its advanced image-guided therapy platforms, interventional imaging systems, and integrated solutions for neurovascular procedures.

Others - Hold a combined 9.9% share, comprising regional neurovascular device manufacturers, catheter technology companies, and emerging medical device firms developing advanced clot retrieval and stroke intervention solutions.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=blood-clot-retrieval-device-market?sai-v

Market Drivers
Increasing prevalence of acute ischemic stroke, rising incidence of cardiovascular diseases, and growing aging population are significantly driving growth of the blood clot retrieval device market worldwide.

Growing adoption of mechanical thrombectomy as the standard of care for large vessel occlusion strokes is accelerating demand for advanced blood clot retrieval devices.

Rising awareness regarding the importance of early stroke diagnosis and timely intervention is strengthening market expansion across developed and emerging healthcare systems.

Advancements in stent retrievers, aspiration catheters, guidewires, and neurovascular access technologies are improving procedural success rates and patient outcomes.

Increasing investments by medical device manufacturers, healthcare providers, and governments in stroke care infrastructure and neurointerventional services are supporting market growth.

Expansion of comprehensive stroke centers, neurovascular treatment facilities, and emergency medical services is increasing accessibility to mechanical thrombectomy procedures worldwide.

Growing demand for minimally invasive neurovascular interventions, improved procedural efficiency, and reduced recovery times is encouraging wider adoption of clot retrieval technologies.

Continuous innovation in device design, imaging guidance systems, and catheter-based technologies is further propelling global blood clot retrieval device market growth.

Industry Developments
Rapid advancement in next-generation stent retrievers, aspiration thrombectomy systems, and combination clot retrieval technologies improving recanalization rates and procedural efficiency.

Increasing adoption of AI-assisted stroke imaging, advanced neurovascular navigation systems, and real-time decision support technologies enhancing treatment speed and clinical outcomes.

Growing investments in clinical research, product development, and next-generation thrombectomy devices accelerating innovation across the neurovascular intervention ecosystem.

Expansion of collaborations among medical device manufacturers, hospitals, research institutions, and stroke care organizations driving development of advanced clot retrieval solutions.

Rising focus on expanding thrombectomy eligibility, improving access to stroke treatment, and optimizing patient care pathways supporting long-term market growth.

Strategic product launches, regulatory approvals, acquisitions, and geographic expansion initiatives by neurovascular device manufacturers strengthening global market competitiveness.

Continuous improvements in catheter flexibility, aspiration performance, clot engagement technologies, and device compatibility enhancing safety, precision, and treatment effectiveness.

Regional Insights
North America 43.5% share: "Leads the market due to advanced stroke care infrastructure, high adoption of mechanical thrombectomy procedures, strong presence of leading neurovascular device manufacturers, favorable reimbursement policies, and increasing awareness of rapid stroke intervention."

Europe 28.2% share: "Strong market presence driven by established stroke treatment networks, increasing adoption of minimally invasive neurovascular procedures, supportive clinical guidelines, and continuous investments in advanced healthcare technologies."

Asia Pacific 21.3% share: "Fastest-growing region supported by rising stroke incidence, expanding healthcare infrastructure, increasing availability of comprehensive stroke centers, and growing adoption of advanced thrombectomy technologies across China, Japan, India, and South Korea."

Latin America 4.0% share: "Growth supported by improving access to neurointerventional procedures, expanding healthcare investments, and increasing awareness of acute stroke treatment, particularly in Brazil and Mexico."

Middle East & Africa 3.0% share: "Emerging growth driven by modernization of healthcare infrastructure, increasing investments in stroke care services, and gradual adoption of advanced neurovascular intervention technologies."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-clot-retrieval-device-market?sai-v

Key Segments
➥ By Product Type
Stent Retrievers: Represents the dominant segment, driven by their high recanalization rates, proven clinical outcomes, and widespread adoption in mechanical thrombectomy procedures for acute ischemic stroke.

Aspiration Catheters: Represents a rapidly growing segment, supported by increasing preference for aspiration-first techniques, faster clot removal, and advancements in large-bore catheter technologies.

Clot Retrieval Accessories: Represents a significant segment, fueled by growing demand for guidewires, microcatheters, balloon guide catheters, and other supporting devices used during thrombectomy procedures.

Others: Represents a moderate segment, supported by continuous innovation in next-generation clot retrieval technologies and combination treatment devices.

➥ By Retrieval Technique
Stent Retriever Technique: Represents the dominant segment, driven by strong clinical evidence, high procedural success rates, and extensive physician familiarity.

Aspiration Technique: Represents a rapidly growing segment, supported by increasing adoption of direct aspiration approaches due to reduced procedure times and improved clinical outcomes.

Combined Technique: Represents a significant segment, fueled by growing use of stent retrievers with aspiration catheters to maximize first-pass success and complete vessel recanalization.

➥ By Application / Use Case
Acute Ischemic Stroke: Represents the dominant segment, driven by the rising global incidence of stroke, increasing awareness of early intervention, and expanding availability of mechanical thrombectomy.

Neurovascular Procedures: Represents a significant segment, supported by growing adoption of clot retrieval devices in complex cerebrovascular interventions.

Others: Represents a moderate segment, fueled by expanding research into peripheral vascular and emerging thrombectomy applications.

➥ By Vessel Location
Intracranial Vessels: Represents the dominant segment, driven by increasing treatment of large vessel occlusions associated with acute ischemic stroke.

Peripheral Vessels: Represents a growing segment, supported by rising adoption of thrombectomy procedures for peripheral arterial and venous occlusions.

Others: Represents a moderate segment, fueled by expanding use in specialized vascular interventions.

➥ By Vessel Compatibility
Large Vessels: Represents the dominant segment, driven by the high prevalence of large vessel occlusion strokes and increasing use of thrombectomy devices in these procedures.

Medium Vessels: Represents a significant segment, supported by technological advancements enabling safe and effective treatment of medium vessel occlusions.

Small Vessels: Represents a growing segment, fueled by ongoing innovation in miniaturized retrieval devices and expanding clinical indications.

➥ By Usage Type
Single-Use Devices: Represents the dominant segment, driven by stringent infection control requirements, regulatory compliance, and consistent device performance.

Reusable Devices: Represents a moderate segment, supported by cost-conscious healthcare facilities and selected clinical settings where reprocessing is permitted.

➥ By End-User
Hospitals: Represents the dominant segment, driven by the availability of comprehensive stroke centers, advanced neurointerventional facilities, and high procedural volumes.

Ambulatory Surgical Centers (ASCs): Represents a growing segment, supported by advancements in minimally invasive vascular procedures and expanding outpatient capabilities.

Specialty Clinics: Represents a significant segment, fueled by increasing availability of specialized neurovascular and cardiovascular treatment services.

Others: Represents a moderate segment, supported by adoption across academic medical centers and research institutions.

➥ By Procurement Channel
Direct Tender: Represents the dominant segment, driven by bulk purchasing agreements between manufacturers and large hospitals or healthcare networks.

Distributors: Represents a significant segment, supported by extensive regional distribution networks and efficient product availability.

Online Procurement & Others: Represents a growing segment, fueled by increasing digital procurement platforms and streamlined supply chain management for medical devices.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.